Best supportive care in clinical trials: review of the inconsistency in control arm design.
Abstract
BACKGROUND:
Best supportive care (BSC) as a control arm in clinical trials is poorly defined. We conducted a review to evaluate clinical trials' concordance with published, consensus-based framework for BSC delivery in trials.
METHODS:
A consensus-based Delphi panel previously identified four key domains of BSC delivery in trials: multidisciplinary care; supportive caredocumentation; symptom assessment; and symptom management. We reviewed trials including BSC control arms from 2002 to 2014 to assess concordance to BSC standards and to selected items from the CONSORT 2010 guidelines.
RESULTS:
Of 408 articles retrieved, we retained 18 after applying exclusion criteria. Overall, trials conformed to the CONSORT guidelines better than the BSC standards (28% vs 16%). One-third of articles offered a detailed description of BSC, 61% reported regular symptom assessment, and 44% reported using validated symptom assessment measures. One-third reported symptom assessment at identical intervals in both arms. None documented evidence-based symptom management. No studies reported educating patients about symptom management or goals of therapy. No studies reported offering access to palliative care specialists.
CONCLUSIONS:
Reporting of BSC in trials is incomplete, resulting in uncertain internal and external validity. Such studies risk systematically over-estimating the net clinical effect of the comparator arms.British Journal of Canceradvance online publication 11 June 2015; doi:10.1038/bjc.2015.192 www.bjcancer.com.
- PMID:
- 26068397
- [PubMed - as supplied by publisher]
No comments:
Post a Comment